← Back to Search

Ultrasound for Evaluating Muscle Health in Cancer Patients

N/A
Waitlist Available
Led By Ying Guo, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients who have a record of weight or BMI over preceding 6-months.
Patients with a biopsy-confirmed solid malignant neoplasm with at least one neurologically-intact lower extremity, who fit into one of the following groups:
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline
Awards & highlights

Study Summary

This trial uses ultrasound to study how well cancer patients' muscles store glycogen, which could help improve their exercise tolerance and function.

Who is the study for?
This trial is for cancer patients with or without cachexia, which involves significant weight loss. Participants must be able to consent and follow study procedures, have a record of their weight or BMI from the past 6 months, and be undergoing physical therapy-led rehabilitation. Excluded are those unable to understand instructions, non-English speakers, patients with unstable medical conditions that limit exercise participation, or those with neurological issues causing muscle atrophy in both lower extremities.Check my eligibility
What is being tested?
The trial is testing how well ultrasound technology (MuscleSound) can measure muscle glycogen levels in cancer patients during rehab. The goal is to use this data for future research on dietary plans and exercises that could improve energy storage in muscles and enhance patient recovery.See study design
What are the potential side effects?
Since the interventions include questionnaire administration, ultrasound evaluation, and physical therapy sessions rather than medication or invasive procedures, there are minimal expected side effects related directly to the trial's interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My weight or BMI has been recorded in the last 6 months.
Select...
I have a confirmed solid tumor and can move at least one of my legs.
Select...
I have lost more than 5% of my weight in the last 6 months without trying, or I've lost over 2% with a BMI under 20.
Select...
I am currently in a rehab program that includes exercise with a physical therapist.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 30 minutes of consent
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 30 minutes of consent for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glycogen Storage Assessment
Other outcome measures
Body Composition
Cancer characteristics of the patient
Functional Independent Measure
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Device feasibility (MuscleSound technology)Experimental Treatment3 Interventions
Patients undergo ultrasound via MuscleSound technology over 3 minutes at baseline and immediately after each of 2 physical therapy sessions comprising cycling or walking over 10 minutes.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ultrasound
2013
Completed Phase 1
~1950
Physical Therapy
2020
Completed Phase 4
~1460

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,609 Previous Clinical Trials
40,915,625 Total Patients Enrolled
18 Trials studying Cachexia
2,475 Patients Enrolled for Cachexia
M.D. Anderson Cancer CenterLead Sponsor
2,958 Previous Clinical Trials
1,798,428 Total Patients Enrolled
3 Trials studying Cachexia
213 Patients Enrolled for Cachexia
Ying Guo, MDPrincipal InvestigatorM.D. Anderson Cancer Center
5 Previous Clinical Trials
1,084 Total Patients Enrolled
1 Trials studying Cachexia
6 Patients Enrolled for Cachexia

Media Library

Ultrasound Clinical Trial Eligibility Overview. Trial Name: NCT03982082 — N/A
Cachexia Research Study Groups: Device feasibility (MuscleSound technology)
Cachexia Clinical Trial 2023: Ultrasound Highlights & Side Effects. Trial Name: NCT03982082 — N/A
Ultrasound 2023 Treatment Timeline for Medical Study. Trial Name: NCT03982082 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it currently possible to join the clinical trial?

"Unfortunately, the trial details on clinicaltrials.gov show that this investigation is not currently recruiting patients. Initially published April 12th 2019, and last updated October 20th 2022, there are no current opportunities for prospective participants; however 121 other studies require volunteers at present."

Answered by AI
~3 spots leftby Dec 2024